Literature DB >> 17130810

Alternatives routes of insulin delivery.

V Lassmann-Vague1, D Raccah.   

Abstract

Optimal glycaemic control is necessary to prevent diabetes-related complications. An intensive treatment, which could mimic physiological insulin secretion, would be the best one. However subcutaneous insulin treatment is not physiologic and represents a heavy burden for patients with type 1 and type 2 diabetes mellitus. Consequently, more acceptable, at least as effective, alternative routes of insulin delivery have been developed over the past years. Up to now, only pulmonary administration of insulin (inhaled insulin) has become a feasible alternative to cover mealtime insulin requirements and one of the various administration systems was recently approved for clinical use in Europe and the United States. But, due to advances in technology, other routes, such as transdermal or oral (buccal and intestinal) insulin administration, could become feasible in a near future, and they could be combined together to offer non-invasive, efficacious and more physiological way of insulin administration to patients with diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17130810     DOI: 10.1016/s1262-3636(06)72804-x

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  8 in total

1.  Inhaled insulin: gone with the wind?

Authors:  C Mathieu; E A M Gale
Journal:  Diabetologia       Date:  2008-01       Impact factor: 10.122

Review 2.  Oral insulin and buccal insulin: a critical reappraisal.

Authors:  Lutz Heinemann; Yves Jacques
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

3.  Intraoral film containing insulin-phospholipid microemulsion: formulation and in vivo hypoglycemic activity study.

Authors:  Heni Rachmawati; Bernard Manuel Haryadi; Kusnandar Anggadiredja; Veinardi Suendo
Journal:  AAPS PharmSciTech       Date:  2014-12-16       Impact factor: 3.246

4.  Oral insulin: a comparison with subcutaneous regular human insulin in patients with type 2 diabetes.

Authors:  Christoph Kapitza; Eric Zijlstra; Lutz Heinemann; M Cristina Castelli; Gary Riley; Tim Heise
Journal:  Diabetes Care       Date:  2010-02-25       Impact factor: 19.112

Review 5.  Developing Insulin Delivery Devices with Glucose Responsiveness.

Authors:  Zejun Wang; Jinqiang Wang; Anna R Kahkoska; John B Buse; Zhen Gu
Journal:  Trends Pharmacol Sci       Date:  2020-11-26       Impact factor: 14.819

6.  Performance of Choline Geranate Deep Eutectic Solvent as Transdermal Permeation Enhancer: An In Vitro Skin Histological Study.

Authors:  Rodrigo Boscariol; Érika A Caetano; Erica C Silva; Thais J Oliveira; Raquel M Rosa-Castro; Marta M D C Vila; Victor M Balcão
Journal:  Pharmaceutics       Date:  2021-04-13       Impact factor: 6.321

Review 7.  Revisiting the Physicochemical Properties and Applications of Deep Eutectic Solvents.

Authors:  Sushma P Ijardar; Vickramjeet Singh; Ramesh L Gardas
Journal:  Molecules       Date:  2022-02-17       Impact factor: 4.411

Review 8.  Drug transport mechanism of oral antidiabetic nanomedicines.

Authors:  Evren Gundogdu; Aysu Yurdasiper
Journal:  Int J Endocrinol Metab       Date:  2014-01-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.